APA

Althoff K., Beckers A., Bell E., Nortmeyer M., Thor T., Sprüssel A., Lindner S., De Preter K., Florin A., Heukamp L. C., Klein-Hitpass L., Astrahantseff K., Kumps C., Speleman F., Eggert A., Westermann F., Schramm A. & Schulte J. H. (20150921). A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies. : Oncogene.

Chicago

Althoff K, Beckers A, Bell E, Nortmeyer M, Thor T, Sprüssel A, Lindner S, De Preter K, Florin A, Heukamp L C, Klein-Hitpass L, Astrahantseff K, Kumps C, Speleman F, Eggert A, Westermann F, Schramm A and Schulte J H. 20150921. A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies. : Oncogene.

Harvard

Althoff K., Beckers A., Bell E., Nortmeyer M., Thor T., Sprüssel A., Lindner S., De Preter K., Florin A., Heukamp L. C., Klein-Hitpass L., Astrahantseff K., Kumps C., Speleman F., Eggert A., Westermann F., Schramm A. and Schulte J. H. (20150921). A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies. : Oncogene.

MLA

Althoff K, Beckers A, Bell E, Nortmeyer M, Thor T, Sprüssel A, Lindner S, De Preter K, Florin A, Heukamp L C, Klein-Hitpass L, Astrahantseff K, Kumps C, Speleman F, Eggert A, Westermann F, Schramm A and Schulte J H. A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies. : Oncogene. 20150921.